stockrow
Friday 6 November 2026
Export ARDT’s income statement to Excel — free account
Ardent Health, Inc.
ARDT Healthcare Medical Care Facilities
Ardent Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.3 billion, up 6.01% from fiscal 2024.
- Revenue
- +3.05%
- EPS
- +288.2%
- Free cash flow
- −23.5%
- Total debt
- −0.72%
Quarter to September 2026, against a year earlier
15.90
2.91
+22.40%
Follow ARDT
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 4 | — | — |
+8 more TTM periods Free account |
| 8.55% | 4.61% | 8.14% | 8.47% | ||
| 2.78% | 1.52% | 2.64% | 2.65% | ||
ROIC |
0.00% | 7.59% | 9.49% | 9.80% | |
Return on Tangible Assets |
12.68% | 3.91% | 6.74% | 6.97% | |
Average Days of Receivables |
37.43 | 39.65 | 38.95 | 39.60 | |
Free Cash Flow per Share |
2.01 | 2.15 | 1.54 | 1.84 | |
Free Cash Flow |
282.30 | 304.76 | 217.99 | 258.61 | |
Capital Expenditures |
(199.57) | (209.56) | (217.08) | (211.90) | |
| Other line items | |||||
Cash ROIC |
7.73% | 8.53% | 6.31% | 7.40% | |
Accounts Receivable Turnover |
9.28 | 8.81 | 8.79 | 8.85 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.21) | (0.19) | (0.20) | (0.20) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 78.48% | 77.51% | 78.00% | |
Share Based Compensation of Revenue |
0.52% | 0.56% | 0.61% | 0.62% | |
Interest Coverage |
0.00 | 5.05 | 6.38 | 5.90 | |
Operating CF/Net income |
3.30 | 6.57 | 3.24 | 3.46 | |
Depreciation/Fixed assets |
0.00 | 0.18 | 0.18 | 0.17 | |
Capex/Depreciation |
(1.18) | (1.25) | (1.30) | (1.32) | |
Revenue per Share |
45.91 | 45.21 | 45.51 | 44.93 | |
Operating CF per Share |
3.43 | 3.63 | 3.08 | 3.34 | |
Capex per Share |
(1.42) | (1.48) | (1.54) | (1.51) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 |
Columns are period end dates · fundamentals updated 5 Nov 2026